Interleukin-18 gene 105A/C genetic polymorphism is associated with the susceptibility of Kawasaki disease

Journal of Clinical Laboratory Analysis

Volumn 23, Issue 2, 2009, Pages 71-76

  Chen, Shih Yin ^a,b   Wan, Lei ^a,b,c   Huang, Yu Chuen ^d,e   Sheu, Jim Jinn Chyuan ^a,b,c   Lan, Yu Ching ^b   Lai, Chih Ho ^f   Lin, Cheng Wen ^b   Jeng, Sheng Chang ^a   Tsai, Yuhsin ^a,b,c   Liu, Shih Ping ^b   Lin, Ying Ju ^a,b,c   Tsai, Fuu Jen ^a,b,c  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c ASIA UNIVERSITY   (Taiwan)

^d MACKAY MEMORIAL HOSPITAL   (Taiwan)

^e INSTITUTE OF PHYSICS   (Taiwan)

^f CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Interleukin 18 (IL 18); Kawasaki disease (KD); Polymorphism

Indexed keywords

INTERLEUKIN 18;

ALLELE; ARTICLE; CHILD; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; RISK FACTOR;

CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; CORONARY VESSELS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; INFANT; INTERLEUKIN-18; LOGISTIC MODELS; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; POLYMORPHISM, SINGLE NUCLEOTIDE; TAIWAN;

EID: 63149172145     PISSN: 08878013     EISSN: 10982825     Source Type: Journal    
DOI: 10.1002/jcla.20292     Document Type: Article

References (40)

1. Taubert KA, Shulman ST. Kawasaki disease. Am Fam Physician 1999;59:3093-3102, 3107-3108.
2. Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children. Arerugi 1967;16:178-222.
3. Falcini F. Kawasaki disease. Curr Opin Rheumatol 2006;18:33-38;
4. Pahlavan PS, Niroomand F. Coronary artery aneurysm: A review. Clin Cardiol 2006;29:439-443.
5. Imai Y, Sunagawa K, Ayusawa M, et al. A fatal case of ruptured giant coronary artery aneurysm. Eur J Pediatr 2006;165:130-133.
6. Freeman AF, Crawford SE, Cornwall ML, Garcia FL, Shulman ST, Rowley AH. Angiogenesis in fatal acute Kawasaki disease coronary artery and myocardium. Pediatr Cardiol 2006;26:578-584.
7. Tsuda E, Hanatani A, Kurosaki K, Naito H, Echigo S. Two young adults who had acute coronary syndrome after regression of coronary aneurysms caused by Kawasaki disease in infancy. Pediatr Cardiol 2006;27:372-375.
8. Wang CL, Wu YT, Liu CA, Kuo HC, Yang KD. Kawasaki disease: Infection, immunity and genetics. Pediatr Infect Dis J 2005;24:998-1004.
9. Sugerman PB, Savage NW, Walsh LJ, et al. The pathogenesis of lichen planus. Crit Rev Oral Biol Med 2002;13:350-365.
10. Simark Mattsson C, Jontell M, Bergenholtz G, Heyden M, Dahlgren UI. Distribution of interferon-gamma mRNA-positive cell in oral lichen planus lesions. J Oral Pathol Med 1998;27:483-488.
11. Simark-Mattsson C, Bergenholtz G, Jontell M, et al. Distribution of interleukin-2-4-10, tumor necrosis factor-alpha and transforming growth factor-beta mRNA in oral lichen planus. Arch Oral Biol 1999;44:499-507.
12. Strober W, Kelsall B, Fuss I, et al. Reciprocal IFN-gamma and TGF-beta responses regulate the occurrence of mucosal inflammation. Immunol Today 1997;18:61-64.
13. Gillespie MT, Horwood NJ. Interleukin-18: Perspectives on the newest interleukin. Cytokine Growth Factor Rev 1998;9:109-116.
14. Gracie JA, Robertson SE, McInnes IB. Interleukin-18. J Leukoc Biol 2003;73:213-224.
15. Gracie JA, Forsey RJ, Chan WL, et al. A proinflammatory role for IL-18 in rheumatoid arthritis. J Clin Invest 1999;104:1393-1401.
16. Aringer M, Smolen JS. Tumour necrosis factor and other proinflammatory cytokines in systemic lupus erythematosus: A rationale for therapeutic intervention. Lupus 2004;13:344-347.
17. Okamura H, Tsutsui H, Komatsu T, et al. Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature 1995;378:88-91.
18. Nakahira M, Ahn HJ, Park WR, et al. Synergy of IL-12 and IL-18 for IFN-gamma gene expression: IL-12-induced STAT4 contributes to IFN-gamma promoter activation by up-regulating the binding activity of IL-18-induced activator protein I. J Immunol 2002;168:1146-1153.
19. Dinarello CA. IL-18: A TH1-inducing, proinflammatory cytokine and new member if the IL-1 family. J Allergy Clin Immunol 1999;103:11-24.
20. Puren AJ, Fantuzzi G, Gu Y, Su MS, Dinarello CA. Interleukin-18 (IFN-gamma-inducing factor) induces IL-8 and IL-1 beta via TNF-alpha production from non-CD141 human blood mononuclear cells. J Clin Invest 1998;101:711-721.
21. Tamura K, Fukuda Y, Sashio H, et al. IL-18 polymorphism is associated with an increased risk of Crohn's disease. J Gastroenterol 2002;37:111-116.
22. Kretowski A, Mironczuk K, Karpinska A, et al. Interleukin-18 promoter polymorphisms in type 1 diabetes. Diabetes 2002;51:3347-3349.
23. Ide A, Kawasaki E, Abiru N, et al. Association between IL-18 gene promoter polymorphisms and CTLA-4 gene 49A/G polymorphism in Japanese patients with type 1 diabetes. J Autoimmun 2004;22:73-78.
24. Kruse S, Kuehr J, Moseler M, et al. Polymorphisms in the IL-18 gene are associated with specific sensitization to common allergens and allergic rhinitis. J Allergy Clin Immunol 2003;111:117-122.
25. Sugiura T, Kawaguchi Y, Harigai M, et al. Association between adult-onset Still's disease and interleukin-18 gene polymorphisms. Genes Immun 2002;3:394-399.
26. Hsueh KC, Lin YJ, Chang JS, et al. Influence of interleukin 18 promoter polymorphisms in susceptibility to Kawasaki disease in Taiwan. J Rheumatol 2008;35:1408-1413.
27. Lin YJ, Wan L, Sheu JJ, et al. A/C polymorphism in the interleukin-18 coding region among Taiwanese systemic lupus erythematosus patients. Lupus 2008;17:124-127.
28. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 2005;21:263-265.
29. Quasney MW, Bronstein DE, Cantor RM, et al. Increased frequency of alleles associated with elevated tumor necrosis factor-α levels in children with Kawasaki disease. Pediatr Res 2001;49:686-690.
30. Wu SF, Chang JS, Wan L, Tsai CH, Tsai FJ. Association of IL-1Ra gene polymorphism, but no association of IL-1β and IL-4 gene polymorphisms, with Kawasaki disease. J Clin Lab Anal 2005;19:99-102.
31. Jin HS, Kim HB, Kim BS, et al. The IL-10 (-627 A/C) promoter polymorphism may be associated with coronary aneurysms and low serum albumin in Korean children with Kawasaki disease. Pediatr Res 2007;61:584-587.
32. Breunis WB, Biezeveld MH, Geissler J, et al. Vascular endothelial growth factor gene haplotypes in Kawasaki disease. Arthritis Rheum 2006;54:1588-1594.
33. Higa S, Hirano T, Mayumi M, et al. Association between interleukin-18 gene polymorphism 105A/C and asthma. Clin Exp Allergy 2003;33:1097-1102.
34. Lee CC, Lin WY, Wan L, et al. Interleukin-18 gene polymorphism, but not interleukin-2 gene polymorphism, is associated with rheumatoid arthritis. Immunogenetics 2007;59:433-439.
35. Giedraitis V, He B, Huang WX, Hillert J. Cloning and mutation analysis of the human IL-18 promoter: A possible role of polymorphisms in expression regulation. J Neuroimmunol 2001;112:146-152.
36. Tone M, Thompson SA, Tone Y, Fairchild PJ, Waldmann H. Regulation of IL-18 (IFN-gamma-inducing factor) gene expression. J Immunol 1997;159:6156-6163.
37. Marshall JD, Aste-Amezaga M, Chehimi SS, Murphy M, Olsen H, Trinchieri G. Regulation of human IL-18 mRNA expression. Clin Immunol 1999;90:15-21.
38. Arimitsu J, Hirano T, Higa S, et al. IL-18 gene polymorphisms affect IL-18 production capability by monocytes. Biochem Biophys Res Commun 2006;342:1413-1416.
39. Haus-Seuffert P, Meisterernst M. Mechanisms of transcriptional activation of cAMP-responsive element-binding protein CREB. Mol Cell Biochem 2000;212:5-9.
40. Dailey L, Roberts SB, Heintz N. Purification of the human histone H4 gene-specific transcription factors H4TF-1 and H4TF-2. Genes Dev 1988;2:1700-1712.